Compare Flux Power Holdings Inc (FLUX) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Flux Power Holdings Inc vs ResMed Inc. — how do they compare? Flux Power Holdings Inc trades at $0.58 (market cap $11.23M), while ResMed Inc. trades at $225.37 (market cap $32.61B). The key difference: ResMed Inc. is far larger — about 2903.8× Flux Power Holdings Inc's market cap, and ResMed Inc. pays a 1.17% dividend while Flux Power Holdings Inc pays none. Which is the better fit depends on your goals.
| FLUX | RMD | |
|---|---|---|
Market Cap | $11.23M | $32.61B |
Sector | Utilities | Health |
52-Week High | $6.66 | $293.73 |
52-Week Low | $0.51 | $182.82 |
Enterprise Value | $17.39M | $31.97B |
Dividend Yield | — | 1.17% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLUX trades at $0.5408, up 3.21% today, but technical indicators signal a bearish trend with selling pressure across moving averages. The company reported revenue of $66.43M in 2025 but a net loss of $6.67M, with profitability metrics like ROE at -52.27% reflecting operational challenges. Recent news highlights product launches like SkyEMS 3.0 and an upcoming earnings call on August 20, 2026.
Despite unanimous analyst buy ratings, FLUX faces significant risks from persistent losses and negative cash flow projections. Investment appeal hinges on execution of growth initiatives in lithium-ion storage, but high volatility and competitive pressures warrant caution for equity investors.
ResMed (RMD) trades at $221.22, up 0.53% with a bullish technical signal and strong fundamental performance. The company delivered four consecutive quarterly earnings beats, with Q4 2026 EPS of $2.95 beating expectations by 2.1%. Revenue grew 9% year-over-year to $1.5 billion, while maintaining robust profitability with 61.1% gross margins and 26.9% net income margins. Recent strategic moves include the $490 million sale of MatrixCare to focus on core sleep and respiratory care markets.
The stock presents a compelling growth story with consistent execution, though near-term headwinds from weak 2027 revenue guidance create uncertainty. Analyst consensus targets $235.00 (6.2% upside) with 40% buy ratings. Key risks include ventilator sales suspension, cost pressures, and competitive threats in the medical device space. The company's strong cash flow generation and shareholder returns ($1.0 billion in 2026) support long-term value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Flux Power Holdings Inc
Flux Power designs and manufactures lithium-ion battery packs for industrial vehicles. Its sustainable energy solutions power material handling equipment like forklifts and airport ground support vehicles.
Read more on FLUX →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
